Condition class · category · California
Vision denials at external review
When a California health plan denied care for vision and the enrollee took it to Independent Medical Review, this is what independent physician reviewers decided.
55.8%
- Overturned
- 43 of 77
- Era
- 2021-2025
- Jurisdiction
- California DMHC IMR
- Published class
- Vision
- Median days to decision
- 40
- All years
- 47.3% of 421
What reviewers relied on
3 validated codesCalifornia requires each published decision to carry “a detailed case summary that includes the specific standards, criteria, and medical and scientific evidence, if any, that led to the case decision” (Health & Safety Code § 1374.33(h)(1)(K)). These are the elements our extraction found in this class, split by how the decision came out.
| What the reviewer relied on | In overturns | In upholds |
|---|---|---|
| the FDA label or approval status | 16%n=43 | 12%n=34 |
| a standardised level-of-care instrument | 0%n=43 | 0%n=34 |
| a California statutory definition | 7%n=43 | 18%n=34 |
Read as description, not instruction. These are patterns in what reviewers wrote, not steps to follow, and no combination of them predicts an outcome. Only codes that cleared the validation gate appear — thirteen did not.
Authorities named in this class
computed- FDA—11
- American Academy of Ophthalmology—6
- American College of Rheumatology—1
- American Society of Plastic Surgeons—1
A rate here is the outcome of decisions that named the authority, not the effect of naming it. Reviewers cite the standard they applied; the citation and the outcome share a cause.
By treatment
computed- Overturned — the reviewer did not sustain the denial
- Upheld — the reviewer sustained the denial
- Pharmacy65.7%35
- Vision Services/Ophthalmology—23
- Reconstructive & plastic procedures—9
- Diagnostic imaging & screening—3
- Diagnostic & physician evaluation—3
- Alternative treatment—1
- Home Health Care—1
- Pain Management—1
The specific treatments inside this class
below n=30, no rate is claimed- Other—24
- Anti-inflammatories—11
- Blepharoplasty—8
- Biologics—7
- Contact Lens—3
- Hormones—3
- SCP Consult Refer—3
- Cataract Surgery—2
By review type
computed- Medical Necessity56.1%66
- Experimental/Investigational—11
Medical-necessity review asks whether the care is needed. Experimental/investigational review asks whether it is likely to be more beneficial than standard therapy — a harder statutory test, and the rates show it.
Every figure on this page is conditional on a denial having reached external review. Fewer than 1% of denials are appealed internally at all, so this describes denials that were fought to the end — not denials in general — and it describes California only. Who this does not cover.
Free help, first: the California DMHC Help Center files your Independent Medical Review at no cost — 1-888-466-2219, dmhc.ca.gov.